Nickson Philip 4
4 · Monte Rosa Therapeutics, Inc. · Filed Jan 4, 2023
Insider Transaction Report
Form 4
Nickson Philip
Chief Business & Legal Officer
Transactions
- Award
Stock Option (Right to Buy)
2023-01-03+123,650→ 123,650 totalExercise: $7.78Exp: 2033-01-02→ Common Stock (123,650 underlying)
Footnotes (1)
- [F1]25% of this option shall vest and become exercisable on January 1, 2024, with the remainder vesting in 36 substantially equal monthly installments thereafter, subject to the Reporting Person's continued service on each such vesting date.